Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine (CROSBI ID 268790)

Prilog u časopisu | Pismo uredniku | međunarodna recenzija

Ljubojević Hadžavdić, Suzana ; Bartolić, Lucija ; Bradamante, Mirna Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine // Acta Dermatovenerologica Croatica, 26 (2018), 3; 262-263

Podaci o odgovornosti

Ljubojević Hadžavdić, Suzana ; Bartolić, Lucija ; Bradamante, Mirna

engleski

Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine

Eosinophilic annular erythema (EAE) is a rare figurate dermatitis of unknown etiology with prominent tissue eosinophilia. A 59-year-old male patient presented with a one-month history of itchy, polycyclic, annular, and partially serpiginous lesions involving the back, the gluteal region, and the extremities. Clinically, EAE is characterized by asymptomatic or mildly pruritic urticarial papules and plaques in annular configuration, mainly on the trunk and proximal extremities. Histologically, as in our patient, EAE is characterized by the appearance of a superficial and deep perivascular inflammatory infiltrate composed of lymphocytes and abundant eosinophils and absence of epidermal change. There is no standard treatment for EAE. Systemic steroids and antimalarials are the usual first- line options. Other treatment options include dapsone, indomethacin, cyclosporine, and UVB therapy. Response to antimalarials is usually observed within the first 2-4 weeks. However, as in our case, it may take several weeks for patients to respond to antimalarial treatment, and complete regression may even take longer. We believe that EAE should be treated with antimalarials over a longer time period in order to avoid frequent relapses.

Eosinophilic annular erythema ; Wells syndrome ; antimalarials

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

26 (3)

2018.

262-263

objavljeno

1330-027X

1847-6538

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost